4-tert-butyl-2-[3-[3-(9-pyridin-2-ylfluoren-9-yl)phenoxy]-5-(2,4,6-trimethylphenyl)phenyl]pyridine
C48H42N2O — CID 159029308
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-tert-butyl-2-[3-[3-(9-pyridin-2-ylfluoren-9-yl)phenoxy]-5-(2,4,6-trimethylphenyl)phenyl]pyridine
4-tert-butyl-2-[3-[3-(9-pyridin-2-ylfluoren-9-yl)phenoxy]-5-(2,4,6-trimethylphenyl)phenyl]pyridine (PubChem CID 159029308) has the molecular formula C48H42N2O and a molecular weight of 662.88 g/mol. Its IUPAC name is 4-tert-butyl-2-[3-[3-(9-pyridin-2-ylfluoren-9-yl)phenoxy]-5-(2,4,6-trimethylphenyl)phenyl]pyridine.
Molecular Properties
| Compound Name | 4-tert-butyl-2-[3-[3-(9-pyridin-2-ylfluoren-9-yl)phenoxy]-5-(2,4,6-trimethylphenyl)phenyl]pyridine |
|---|---|
| PubChem CID | 159029308 |
| Molecular Formula | C48H42N2O |
| Molecular Weight | 662.88 g/mol |
| Exact Mass | 662.33 |
| IUPAC Name | 4-tert-butyl-2-[3-[3-(9-pyridin-2-ylfluoren-9-yl)phenoxy]-5-(2,4,6-trimethylphenyl)phenyl]pyridine |
| SMILES | Cc1cc(C)c(-c2cc(Oc3cccc(C4(c5ccccn5)c5ccccc5-c5ccccc54)c3)cc(-c3cc(C(C)(C)C)ccn3)c2)c(C)c1 |
| InChI | InChI=1S/C48H42N2O/c1-31-24-32(2)46(33(3)25-31)35-26-34(44-30-36(21-23-49-44)47(4,5)6)27-39(28-35)51-38-15-13-14-37(29-38)48(45-20-11-12-22-50-45)42-18-9-7-16-40(42)41-17-8-10-19-43(41)48/h7-30H,1-6H3 |
| InChIKey | TZUXJDVRFZPTPL-UHFFFAOYSA-N |
| XLogP | 12.19 |
| TPSA | 35.01 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 662.88 |
| LogP ≤ 5 | 12.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159029308 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.